Home/Filings/4/0000819689-11-000024
4//SEC Filing

ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ 4

Accession 0000819689-11-000024

CIK 0000819689operating

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 3:41 PM ET

Size

7.8 KB

Accession

0000819689-11-000024

Insider Transaction Report

Form 4
Period: 2011-05-19
ROUSE JAMES E
DirectorPresident & CEO
Transactions
  • Award

    Stock Option

    2011-06-06$5.73/sh+10,000$57,30037,000 total
    Exercise: $5.73Exp: 2021-06-06Common Stock (10,000 underlying)
  • Award

    Stock Option

    2011-05-19$9.86/sh+10,000$98,60027,000 total
    Exercise: $9.86Exp: 2021-05-19Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]The option holder may exercise purchase rights for 2,000 shares on or after 05/19/2012, and 2,000 each on or after anniversary date each year until 10,000 are exercised.
  • [F2]The option holder may exercise purchase rights for 2,000 shares on or after 06/06/2012, and 2,000 each on or after anniversary date each year until 10,000 are exercised.

Issuer

ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/

CIK 0000819689

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000819689

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 3:41 PM ET
Size
7.8 KB